Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

Do multi-cancer detection tests provide a net benefit? NCI aims to answer this question, beginning with the Vanguard feasibility trial which recently started accruing patients.

July 30, 2025

Vol.51 No.29

City of Hope brings evidence-based approaches to integrative oncology

The landscape of cancer care is evolving rapidly, with growing recognition that optimal patient outcomes require a whole-person care approach that goes beyond cytotoxic and targeted therapies.

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

NCI announced that the paylines for R01 grants for established and new investigators are expected to drop to the 4th percentile—a historic low for the institute.

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

NCI has initiated a pilot study to address the feasibility of using multi-cancer detection, or MCD, tests in future randomized controlled trials.

July 18, 2025

Vol.51 No.28

Clinical Roundup

Ohio State launches pancreatic cancer trial via telehealth

The Ohio State University Comprehensive Cancer has launched a first-of-its-kind clinical trial.

July 18, 2025

Vol.51 No.28

Cancer Policy

Supreme Court lifts lower-court freeze on RIFs

The U.S. Supreme Court has temporarily lifted a lower court’s freeze on the Trump administration’s reductions in force, or RIFs, freeing the government to continue their large-scale restructuring of the federal government.

July 11, 2025

Vol.51 No.27

By Jacquelyn Cobb

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

YOU MAY BE INTERESTED IN

In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.

City of Hope brings evidence-based approaches to integrative oncology

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

Ohio State launches pancreatic cancer trial via telehealth

Supreme Court lifts lower-court freeze on RIFs

Renew today!

Subscriber content

Never miss an issue!

Login